Understanding the relationship between cuproptosis and the development of hepatocellular carcinoma: implications for targeted therapies

被引:5
作者
Zhu, Haixia [1 ,2 ]
Zhao, Yamin [3 ]
Wang, Yaxuan [1 ,2 ]
Wei, Guohua [1 ,2 ]
Liu, Jibin [1 ,2 ]
机构
[1] Nantong Univ, Affiliated Tumor Hosp, Inst Oncol, Nantong, Peoples R China
[2] Nantong Tumor Hosp, Nantong, Peoples R China
[3] Second Peoples Hosp Nantong, Internal Med, Nantong, Peoples R China
关键词
hepatocellular carcinoma; cuproptosis; prognosis; treatment resistance; immune microenvironment; SENSITIVITY;
D O I
10.3389/fimmu.2025.1557223
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatocellular carcinoma (HCC) presents a significant global health challenge, particularly in developing countries where its incidence is markedly elevated. Despite advancements in treatment modalities, the high malignancy, metastatic potential, and drug resistance associated with HCC contribute to poor clinical outcomes, underscoring the necessity for a more profound understanding of its pathogenesis. This review meticulously examines the role of copper apoptosis, a novel form of programmed cell death linked to dysregulated copper metabolism, in the development and progression of HCC. By conducting a comprehensive review of recent literature and experimental studies, we elucidate the molecular mechanisms through which excess copper induces oxidative stress, pyroptosis, and ferroptosis, thereby influencing tumorigenesis and progression. This review offers valuable insights into the intricate relationship between copper metabolism and HCC, positioning copper apoptosis as a potential therapeutic target to enhance treatment strategies and improve patient outcomes.
引用
收藏
页数:7
相关论文
共 50 条
[41]   Development of sorafenib and other molecularly targeted agents in hepatocellular carcinoma [J].
Zhu, Andrew X. .
CANCER, 2008, 112 (02) :250-259
[42]   Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma [J].
Caecilia HC Sukowati ;
Natalia Rosso ;
Lory S Crocè ;
Claudio Tiribelli .
World Journal of Hepatology, 2010, 2 (03) :114-126
[43]   Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma [J].
Sukowati, Caecilia H. C. ;
Rosso, Natalia ;
Croce, Lory S. ;
Tiribelli, Claudio .
WORLD JOURNAL OF HEPATOLOGY, 2010, 2 (03) :114-126
[44]   Spontaneous regression of hepatocellular carcinoma is possible and might have implications for future therapies [J].
Randolph, Adam C. ;
Tharalson, Erin M. ;
Gilani, Nooman .
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (08) :804-809
[45]   The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies [J].
Kang, Yongbo ;
Cai, Yue ;
Yang, Ying .
LIVER CANCER, 2022, 11 (02) :113-125
[46]   Advances in Understanding Hepatocellular Carcinoma Vasculature: Implications for Diagnosis, Prognostication, and Treatment [J].
Rhee, Hyungjin ;
Park, Young Nyun ;
Choi, Jin-Young .
KOREAN JOURNAL OF RADIOLOGY, 2024, 25 (10) :887-901
[47]   Relationship Between Serum Heparanase and Microscopic Venous Invasion in Patients With Hepatocellular Carcinoma [J].
Wang, Gui-Bo ;
Zhou, Xin-Yu ;
Wang, Xiao-Qin .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2010, 134 (02) :242-248
[48]   The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma [J].
Yuan, Huiyang ;
Qin, Xin ;
Wang, Jing ;
Yang, Qingya ;
Fan, Yidong ;
Xu, Dawei .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[49]   Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study [J].
Gan, Biling ;
Wu, Lei ;
Zhou, Shunan ;
Chen, Zhihong ;
Wu, Fan ;
Xu, Lianqun ;
Chen, Zhenrong ;
Ma, Honghui ;
He, Peijia ;
Fang, Dan ;
Shi, Ning .
FRONTIERS IN IMMUNOLOGY, 2025, 16
[50]   Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma [J].
Goh Eun Chung ;
Jeong-Hoon Lee ;
Jung-Hwan Yoon ;
Sun Jung Myung ;
Kyoungbun Lee ;
Ja June Jang ;
Jeong Min Lee ;
Se-Hyung Kim ;
Kyung-Suk Suh ;
Yoon Jun Kim ;
Hyo-Suk Lee .
Abdominal Imaging, 2012, 37 :439-446